The recent Supreme Court judgment dismissing pharma giant Novartis’ claim for patent protections in India for its award-winning and prohibitively priced anti-leukemia drug Glivec has renewed the focus on accessibly-priced drugs – in particular the failure of the Indian public healthcare system and health policy to ensure affordable drugs for all. Studies show that as much as 70% of health spending in India comes from out-of-pocket payments, with 50-80% of...

-The Hindustan Times Far from the neatly trimmed lawns of India Gate that so often reverberate with cries for justice, far also from the corridors of power where ministries recently squabbled over the right age for consensual sex, lie 197 districts - yes 197, read the figure again - where children are regularly abused. In these districts -- all ridden by conflict -- words like illegal detention, arbitrary arrests, sexual violence, torture...

-The Hindu The Act grants legal recognition to the rights of traditional forest dwelling communities Jawhar (Thane): The Additional Collector's headquarter here was abuzz even before its gates opened on Monday morning. Around 100 tribals from various villages in the Jawhar tehsil had already queued to begin what they had aptly named as first of its kind ‘RTI Satyagraha' against the alleged unlawful implementation of The Scheduled Tribes and Other Traditional Forest...

-The Hindu Forest rights campaigners have slammed the satellite image-based study on the implementation of the Forest Rights Act (FRA) in Maharashtra as "deeply faulty and obviously biased," arguing that it manipulates data and facts to make a case against the Act. Countering the report which a private company prepared at the behest of the State Forest Department, a critique by Madhu Sarin and others of the Campaign for Survival and Dignity...

-The Indian Express India is no insecure dictatorship junking international obligations for cheap populism. The highest court of the world's largest democracy has made a nuanced distinction between real innovation and marketing gimmickry. Yet, the Swiss pharmaceutical giant Novartis's response to the recent Supreme Court verdict in Novartis vs Union of India has been imperial in tone. The judgment "discourages innovative drug discovery", it claimed. It accused Indian law of lagging...